David Spetzler, MS, MBA, PhD

VP Discovery Research

Dr. Spetzler joined the Caris scientific team in August of 2009, where he currently leads the protein biomarker discovery group in the Research and Development division of Caris. His team is focused on the development of noninvasive biomarker capture technologies to identify and predict early stage cancer. In addition, he and his team develop new molecular assays for Caris and our pharmaceutical partners.

Prior to his position at Caris, Dr. Spetzler was a post-doctoral fellow at Arizona State University where he developed multiplexed nanotechnologies for single molecule detection of nucleic acid and protein targets. He also developed novel methods of using DNA to create biological computers to solve NP-complete optimization problems, and built a novel optical detection system capable of measuring single molecule protein conformational changes with microsecond time resolution. He earned a master of science from the math department in Computational Bioscience, a PhD in Molecular Biology, and a MBA from Arizona State University. He has published numerous research articles, been a scientific and commercial reviewer for SBIR/STTR grants for NSF, and holds 3 provisional patents.